Nyxoah (NYXH) Income from Continuing Operations (2021 - 2026)

Nyxoah's (NYXH) quarterly Income from Continuing Operations came in at 18210234.43 in Q1 2026, down 22.23% year-on-year from 23414027.23 in Q1 2025, and down 99.93% quarter-over-quarter from 25286517269.8 in Q4 2025.

Nyxoah (NYXH) Income from Continuing Operations (2021 - 2026) Analysis & Trends

Nyxoah's Income from Continuing Operations history runs 6 years deep, the most recent figure standing at 18210234.43 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 22.23% year-over-year to 18210234.43 in Q1 2026; TTM through Mar 2026 was 25253786209.52, a 282.32% increase from a year earlier, with the FY2025 full-year figure at 105792930.79, down 61.6% from the prior year.
  • Income from Continuing Operations fell to 18210234.43 in Q1 2026 per NYXH's latest filing, from 25286517269.8 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 25286517269.8 in Q4 2025 and bottomed at 13879985652.71 in Q4 2024.
  • The 5-year median for Income from Continuing Operations is 6160556.15 (2022), against an average of 15455630.54.
  • Across the five-year window, Income from Continuing Operations surged 1567.57% in 2022 and tumbled 175602.68% in 2023, its largest moves.
  • Year by year, Income from Continuing Operations stood at 13565208968.99 in 2022, then sank by 191.57% to 12421726249.19 in 2023, then slipped by 11.74% to 13879985652.71 in 2024, then surged by 282.18% to 25286517269.8 in 2025, then tumbled by 99.93% to 18210234.43 in 2026.
  • Per Business Quant, the three latest NYXH Income from Continuing Operations figures stand at 18210234.43 (Q1 2026), 25286517269.8 (Q4 2025), and 28244371.01 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 240.00 Mn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 823.20 Mn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -37.00 Mn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 239.00 Mn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 398.73 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 147.90 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -77.90 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 13.00 Mn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 112.77 Mn
10 Nyxoah 56.02 Mn 103.00 Mn 4.26 Mn 18.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.21 Mn
Dec 31, 2025 25.29 Bn
Sep 30, 2025 -28.24 Mn
Jun 30, 2025 -22.70 Mn
Mar 31, 2025 23.41 Mn
Dec 31, 2024 -13.88 Bn
Sep 30, 2024 18.73 Mn
Jun 30, 2024 -13.18 Mn
Mar 31, 2024 132.31 Mn
Dec 31, 2023 -12.42 Bn
Sep 30, 2023 8.29 Mn
Jun 30, 2023 -11.91 Mn
Mar 31, 2023 -12.39 Bn
Dec 31, 2022 13.57 Bn
Sep 30, 2022 -6.16 Mn
Jun 30, 2022 -5.10 Mn
Mar 31, 2022 -7.05 Mn
Dec 31, 2021 -924.33 Mn
Sep 30, 2021 -10.01 Mn
Jun 30, 2021 8.12 Mn